Hao Bai

USPTO Granted Patents = 16 (Patent Applications = 1)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 6.9

ph-index = 5

Forward Citations = 83(Granted Patents)

Location History:

Grayslake, IL (US) (2000)
Libertyville, IL (US) (2002)
San Diego, CA (US) (2003 - 2022)

Company Filing History:

9 out of 3,868

Nitto-denko Corporation

patents

5 out of 4,177

Abbott Laboratories Corporation

Years Active: 2000-2025

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12440445 - Fusogenic compounds for delivery of biologically active molecules (2025-10-14),

2. 12319643 - Ionizable compounds and compositions and uses thereof (2025-06-03),

3. 11413243 - Fusogenic compounds for delivery of biologically active molecules (2022-08-16),

4. 11384051 - Ionizable compounds and compositions and uses thereof (2022-07-12),

5. 10167253 - Ionizable compounds and compositions and uses thereof (2019-01-01),

6. 10080737 - Polymer-based hydrotropes for hydrophobic drug delivery (2018-09-25),

7. 9839694 - Reduction of endotoxins from polyanionic polymer conjugates (2017-12-12),

8. 9636411 - Large scale process for preparing poly (glutamyl-glutamate) conjugates (2017-05-02),

9. 9295728 - Co-polymer conjugates (2016-03-29),

10. 8119624 - Fused phenyl amido heterocyclic compounds (2012-02-21),

11. 7842713 - Fused phenyl amido heterocyclic compounds (2010-11-30),

12. 6645968 - Potassium channel openers (2003-11-11),

13. 6437138 - 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission (2002-08-20),

14. 6403575 - 3-Pyridyl enantiomers and their use as analgesics (2002-06-11),

15. 6133253 - 3-Pyridyl enantiomers and their use as analgesics (2000-10-17),

Title: Innovator Spotlight: Hao Bai

Introduction:

Hao Bai, a renowned inventor based in San Diego, CA, has made significant contributions to the field of biopharmaceuticals and therapeutics. With a remarkable portfolio of 14 patents, his innovative work has paved the way for the development of novel nanoparticle compositions for the delivery of biologically active molecules.

Latest Patents:

Bai's latest patents showcase his expertise in fusogenic compounds for the delivery of biologically active molecules. These compounds, along with their compositions and methods of use, have revolutionized the encapsulation and delivery of active agents, particularly nucleic acid agents, to cells, tissues, organs, and subjects. His inventions have far-reaching implications for the advancement of targeted drug delivery systems in the medical industry.

Career Highlights:

Having worked at reputable companies such as Nitto-Denko Corporation and Abbott Laboratories Corporation, Bai has honed his skills and expertise in the field of pharmaceuticals and biotechnology. His innovative approach to drug delivery systems has garnered recognition and praise from industry experts and peers alike.

Collaborations:

Throughout his career, Bai has collaborated with esteemed professionals in the field, including Kwok Yin Tsang and Mark W Holladay. Together, they have pushed the boundaries of scientific research and development, leading to groundbreaking advancements in the field of biopharmaceuticals.

Conclusion:

In conclusion, Hao Bai's relentless pursuit of innovation and his dedication to advancing drug delivery technologies have established him as a visionary inventor in the realm of biopharmaceuticals. His patents stand as a testament to his ingenuity and his commitment to improving the efficacy of drug delivery systems for the betterment of healthcare worldwide.

This text is generated by artificial intelligence and may not be accurate.